Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
- PMID: 30774829
- PMCID: PMC6375376
Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
Abstract
Background: The present study was conducted to determine the response to treatment in patients with GTN, the survival rate and to investigate the outcomes of first pregnancy after chemotherapy. Materials and Methods: The treatment protocol was based on the FIGO Staging of GTN and the Modified WHO Prognostic Scoring. Results: Complete remission was achieved with MTX in 100% of the low-risk patients and with combination therapy in 91% of the high-risk cases. Out of 27 low-risk patients, 21 had no metastasis 6 had lung metastasis, 18 preserved their fertility and conceived in the first year following the chemotherapy. Out of 3 patients who had developed invasive moles, 1 got pregnant after chemotherapy. Four of the patients with choriocarcinoma conceived in the first year following the chemotherapy. In the patient with placental site trophoblastic tumors, there was no pregnancy due to hysterectomy. Conclusion: GTN was found to be a chemosensitive condition, but more effective therapeutic protocols are therefore required.
Keywords: Choriocarcinoma; Gestational trophoblastic neoplasia; High dose chemotherapy; Pregnancy.
Similar articles
-
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.Clin Transl Oncol. 2015 May;17(5):409-15. doi: 10.1007/s12094-014-1251-1. Epub 2014 Nov 15. Clin Transl Oncol. 2015. PMID: 25398721
-
Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.Clin Oncol (R Coll Radiol). 2014 Jan;26(1):39-44. doi: 10.1016/j.clon.2013.08.010. Epub 2013 Sep 17. Clin Oncol (R Coll Radiol). 2014. PMID: 24051171
-
[Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].Gynecol Obstet Fertil. 2007 Mar;35(3):205-15. doi: 10.1016/j.gyobfe.2006.12.023. Epub 2007 Feb 28. Gynecol Obstet Fertil. 2007. PMID: 17336125 French.
-
Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.Am J Obstet Gynecol. 2011 Jan;204(1):11-8. doi: 10.1016/j.ajog.2010.06.072. Epub 2010 Aug 24. Am J Obstet Gynecol. 2011. PMID: 20739008 Review.
-
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN).Cancers (Basel). 2022 Jun 3;14(11):2782. doi: 10.3390/cancers14112782. Cancers (Basel). 2022. PMID: 35681761 Free PMC article. Review.
Cited by
-
Gestational Trophoblastic Disease: Complete versus Partial Hydatidiform Moles.Diseases. 2024 Jul 17;12(7):159. doi: 10.3390/diseases12070159. Diseases. 2024. PMID: 39057130 Free PMC article. Review.
-
Predicting monotherapy resistance risk in patients with low-risk gestational trophoblastic neoplasia: integration of the systemic immune-inflammation index and the prognostic nutritional index.Front Oncol. 2024 Oct 1;14:1368543. doi: 10.3389/fonc.2024.1368543. eCollection 2024. Front Oncol. 2024. PMID: 39411133 Free PMC article.
-
Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia.Caspian J Intern Med. 2023 Winter;14(1):47-52. doi: 10.22088/cjim.14.1.47. Caspian J Intern Med. 2023. PMID: 36741497 Free PMC article.
References
-
- Bracken MB. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol. 1987;94(12):1123–35. - PubMed
-
- Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39(3):155–62. - PubMed
-
- Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717–29. - PubMed
-
- Newlands ES, Paradinas FJ, Fisher RA. Recent advances in gestational trophoblastic disease. Hematol Oncol Clin North Am. 1999;13(1):225–44. - PubMed
-
- Mangili G, Lorusso D, Brown J, et al. Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S109–16. - PubMed
LinkOut - more resources
Full Text Sources